EUCTR2009-011397-14-DE进行中（未招募）1 期
Effect of anti-TNF-alpha therapy on endothelial progenitor cells and endothelial dysfunction in patients with psoriasis without risk factors for atherosclerosis - EPPSOR-Studie
Technical University of Dresden0 个研究点目标入组 0 人开始时间: 2009年8月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Patients aged between 18 and 50 years. The aim of this age restiction is to emphasize that the study population is propably not affected by common arteriosclerosis because of their age.
- •- Moderate to severe chronic plaque psoriasis (PASI = 10, BSA = 10, DLQI = 10)
- •- Indication for therapy with etanercept
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Conventional cardiovascular risk factors
- •- Contraindication for etanercept, accordingly to the approved guidelines
研究者
相似试验
已完成
4 期
Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)Ankylosing Spondylitis(AS)NCT01212653Chinese University of Hong Kong50
已完成
不适用
Effect of anti-tumour necrosis factor alpha (TNFa) therapy on blood vessel health in patients with rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisRheumatoid arthritisISRCTN57761809niversity of Dundee (UK)90
招募中
不适用
Effect of interruption of TNFi on endothelial function in patients with rheumatoid arthritisreumatoide artritis1002321310003216NL-OMON37380niversitair Medisch Centrum Sint Radboud48
已完成
2 期
Effect of Infliximab on treatment of cirrhosis.Cryptogenic cirrhosis.Other and unspecified cirrhosis of liverIRCT2016052228003N1Research center for infectious diseases of digestive system, research adjutancy of Ahvaz Jundishapur30
进行中（未招募）
不适用
Effects of Etanercept on Endothelial Function and Carotid Intima-Media Thickness In Patients With Active Ankylosing Spondylitis: a 52-Weeks, Randomized, Double Blind, Placebo-Controlled Study - CRESTAnkylosing SpondylitisEUCTR2007-003096-39-ITWYETH LEDERLE